Proteomics of protein post-translational modifications implicated in neurodegeneration

Translational Neurodegeneration

Volumn 3, Issue 1, 2014, Pages

  Ren, Ru Jing ^a   Dammer, Eric B ^a   Wang, Gang ^a   Seyfried, Nicholas T ^a   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Neurodegeneration; Parkinson's disease; Protein posttranslational modifications; Proteomics

Indexed keywords

AMYLOID BETA PROTEIN; HISTONE; LECTIN; PHOSPHOPEPTIDE; PROTEOME;

AFFINITY CHROMATOGRAPHY; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; CARBOXY TERMINAL SEQUENCE; DERIVATIZATION; HUMAN; HUNTINGTON CHOREA; MASS SPECTROMETRY; MEASUREMENT ACCURACY; NERVE DEGENERATION; PARKINSON DISEASE; PATHOGENESIS; PEPTIDE AFFINITY PURIFICATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEOMICS; QUALITY CONTROL; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84920852152     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-3-23     Document Type: Review

References (157)

1. Duchen MR: Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Arch 2012, 464:111-121. 10.1007/s00424-012-1112-0.
2. Jicha GA, Carr SA: Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimers Dis 2010, 19:253-272.
3. Taylor JP, Hardy J, Fischbeck KH: Toxic proteins in neurodegenerative disease. Science 2002, 296:1991-1995. 10.1126/science.1067122.
4. Hardy J: Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. Biochem Soc Trans 2005, 33:578-581.
5. Balch WE, Morimoto RI, Dillin A, Kelly JW: Adapting proteostasis for disease intervention. Science 2008, 319:916-919. 10.1126/science.1141448.
6. Huang Y, Chegini F, Chua G, Murphy K, Gai W, Halliday G: Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T alpha-synuclein mutation. Transl Neurodegener 2012, 1:2. 10.1186/2047-9158-1-2.
7. Kelleher NL: A cell-based approach to the human proteome project. J Am Soc Mass Spectrom 2012, 23:1617-1624. 10.1007/s13361-012-0469-9.
8. Tran JC, Zamdborg L, Ahlf DR, Lee JE, Catherman AD, Durbin KR, Tipton JD, Vellaichamy A, Kellie JF, Li M: Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 2011, 480:254-258. 10.1038/nature10575.
9. Butterfield DA: Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 2004, 1000:1-7. 10.1016/j.brainres.2003.12.012.
10. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R: Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal 2012, 17:1610-1655. 10.1089/ars.2011.4109.
11. Butterfield DA, Perluigi M, Sultana R: Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006, 545:39-50. 10.1016/j.ejphar.2006.06.026.
12. Farias AS, Pradella F, Schmitt A, Santos LM, Martins-de-Souza D: Ten years of proteomics in multiple sclerosis. Proteomics 2014, 14:467-480. 10.1002/pmic.201300268.
13. Johnson MD, Yu LR, Conrads TP, Kinoshita Y, Uo T, McBee JK, Veenstra TD, Morrison RS: The proteomics of neurodegeneration. Am J Pharmacogenomics 2005, 5:259-270. 10.2165/00129785-200505040-00006.
14. Lovestone S, Guntert A, Hye A, Lynham S, Thambisetty M, Ward M: Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers. Expert Rev Proteomics 2007, 4:227-238. 10.1586/14789450.4.2.227.
15. Schulenborg T, Schmidt O, van Hall A, Meyer HE, Hamacher M, Marcus K: Proteomics in neurodegeneration-disease driven approaches. J Neural Transm 2006, 113:1055-1073. 10.1007/s00702-006-0512-8.
16. Westman-Brinkmalm A, Ruetschi U, Portelius E, Andreasson U, Brinkmalm G, Karlsson G, Hansson S, Zetterberg H, Blennow K: Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases. Front Biosci (Landmark Ed) 2009, 14:1793-1806.
17. Zhang J, Keene CD, Pan C, Montine KS, Montine TJ: Proteomics of human neurodegenerative diseases. J Neuropathol Exp Neurol 2008, 67:923-932. 10.1097/NEN.0b013e318187a832.
18. Donovan LE, Dammer EB, Duong DM, Hanfelt JJ, Levey AI, Seyfried NT, Lah JJ: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease. Alzheimers Res Ther 2013, 5:32. 10.1186/alzrt186.
19. Mohanty J, Shukla H, Williamson J, Launer L, Saxena S, Rifkind J: Alterations in the red blood cell membrane proteome in Alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci 2010, 8:11. 10.1186/1477-5956-8-11.
20. Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, Funderburk C, Peng J, Lah JJ, Levey AI: Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. J Proteome Res 2009, 8:5069-5079. 10.1021/pr900474t.
21. Dammer EB, Duong DM, Diner I, Gearing M, Feng Y, Lah JJ, Levey AI, Seyfried NT: Neuron enriched nuclear proteome isolated from human brain. J Proteome Res 2013, 12:3193-3206. 10.1021/pr400246t.
22. Gozal YM, Dammer EB, Duong DM, Cheng D, Gearing M, Rees HD, Peng J, Lah JJ, Levey AI: Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology. Front Neurol 2011, 2:1-11.
23. Bai B, Hales CM, Chen P-C, Gozal Y, Dammer EB, Fritz JJ, Wang X, Xia Q, Duong DM, Street C: U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci 2013, 110:16562-16567. 10.1073/pnas.1310249110.
24. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I: Progress with gene-product mapping of the mollicutes: mycoplasma genitalium. Electrophoresis 1995, 16:1090-1094. 10.1002/elps.11501601185.
25. Rodolfo C, Ciccosanti F, Giacomo GD, Piacentini M, Fimia GM: Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases. Expert Rev Proteomics 2010, 7:519-542. 10.1586/epr.10.43.
26. Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J: Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 2004, 279:39155-39164. 10.1074/jbc.M405456200.
27. Aillet F, Lopitz-Otsoa F, Hjerpe R, Torres-Ramos M, Lang V, Rodriguez MS: Isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. Methods Mol Biol 2012, 832:173-183. 10.1007/978-1-61779-474-2_12.
28. Lopitz-Otsoa F, Rodriguez-Suarez E, Aillet F, Casado-Vela J, Lang V, Matthiesen R, Elortza F, Rodriguez MS: Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs). J Proteome 2012, 75:2998-3014. 10.1016/j.jprot.2011.12.001.
29. Jeram SM, Srikumar T, Zhang X-D, Anne Eisenhauer H, Rogers R, Pedrioli PGA, Matunis M, Raught B: An improved SUMmOn-based methodology for the identification of ubiquitin and ubiquitin-like protein conjugation sites identifies novel ubiquitin-like protein chain linkages. Proteomics 2010, 10:254-265. 10.1002/pmic.200900648.
30. Dammer EB, Na CH, Xu P, Seyfried NT, Duong DM, Cheng D, Gearing M, Rees H, Lah JJ, Levey AI: Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem 2011, 286:10457-10465. 10.1074/jbc.M110.149633.
31. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D, Gygi SP: A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 2003, 21:921-926. 10.1038/nbt849.
32. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J, Hochstrasser M, Finley D, Peng J: Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009, 137:133-145. 10.1016/j.cell.2009.01.041.
33. Na CH, Jones DR, Yang Y, Wang X, Xu Y, Peng J: Synaptic protein ubiquitination in rat brain revealed by antibody-based ubiquitome analysis. J Proteome Res 2012, 11:4722-4732. 10.1021/pr300536k.
34. Udeshi ND, Mertins P, Svinkina T, Carr SA: Large-scale identification of ubiquitination sites by mass spectrometry. Nat Protoc 2013, 8:1950-1960. 10.1038/nprot.2013.120.
35. Matsumoto ML, Wickliffe KE, Dong KC, Yu C, Bosanac I, Bustos D, Phu L, Kirkpatrick DS, Hymowitz SG, Rape M: K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol Cell 2010, 39:477-484. 10.1016/j.molcel.2010.07.001.
36. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, Dugger D, Gordon N, Sidhu SS, Fellouse FA: Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008, 134:668-678. 10.1016/j.cell.2008.07.039.
37. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J: Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev 2010, 29:79-125.
38. Bunkenborg J, Pilch BJ, Podtelejnikov AV, Wisniewski JR: Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 2004, 4:454-465. 10.1002/pmic.200300556.
39. Kaji H, Yamauchi Y, Takahashi N, Isobe T: Mass spectrometric identification of N-linked glycopeptides using lectin-mediated affinity capture and glycosylation site-specific stable isotope tagging. Nat Protoc 2007, 1:3019-3027. 10.1038/nprot.2006.444.
40. Ruiz-May E, Catala C, Rose JK: N-glycoprotein enrichment by lectin affinity chromatography. Methods Mol Biol 2014, 1072:633-643. 10.1007/978-1-62703-631-3_43.
41. Owen JB, Di Domenico F, Sultana R, Perluigi M, Cini C, Pierce WM, Butterfield DA: Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD. J Proteome Res 2009, 8:471-482. 10.1021/pr800667a.
42. Di Domenico F, Owen JB, Sultana R, Sowell RA, Perluigi M, Cini C, Cai J, Pierce WM, Butterfield DA: The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression. J Neurosci Res 2010, 88:3566-3577. 10.1002/jnr.22528.
43. Yao X: Derivatization or not: a choice in quantitative proteomics. Anal Chem 2011, 83:4427-4439. 10.1021/ac200925p.
44. Phanstiel D, Zhang Y, Marto JA, Coon JJ: Peptide and protein quantification using iTRAQ with electron transfer dissociation. J Am Soc Mass Spectrom 2008, 19:1255-1262. 10.1016/j.jasms.2008.05.023.
45. Ting L, Rad R, Gygi SP, Haas W: MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Methods 2011, 8:937-940. 10.1038/nmeth.1714.
46. Evans AR, Robinson RA: Global combined precursor isotopic labeling and isobaric tagging (cPILOT) approach with selective MS (3) acquisition. Proteomics 2013, 13:3267-3272. 10.1002/pmic.201300198.
47. Robinson RAS, Evans AR: Enhanced sample multiplexing for nitrotyrosine-modified proteins using combined precursor isotopic labeling and isobaric tagging. Anal Chem 2012, 84:4677-4686. 10.1021/ac202000v.
48. Schilling O, Barré O, Huesgen PF, Overall CM: Enrichment of natural and proteolytically generated protein C-termini on a proteome-wide scale. Protoc Exch 2010. Epub only
49. Schilling O, Barré O, Huesgen PF, Overall CM: Proteome-wide analysis of protein carboxy termini: C terminomics. Nat Methods 2010, 7:508-511. 10.1038/nmeth.1467.
50. Kleifeld O, Doucet A, auf dem Keller U, Prudova A, Schilling O, Kainthan RK, Starr AE, Foster LJ, Kizhakkedathu JN, Overall CM: Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010, 28:281-288. 10.1038/nbt.1611.
51. Lopez-Otin C, Overall CM: Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002, 3:509-519. 10.1038/nrm858.
52. van den Berg BHJ, Tholey A: Mass spectrometry-based proteomics strategies for protease cleavage site identification. Proteomics 2012, 12:516-529. 10.1002/pmic.201100379.
53. Zhan X, Desiderio DM: Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal Biochem 2006, 354:279-289. 10.1016/j.ab.2006.05.024.
54. Garcia BA, Mollah S, Ueberheide BM, Busby SA, Muratore TL, Shabanowitz J, Hunt DF: Chemical derivatization of histones for facilitated analysis by mass spectrometry. Nat Protoc 2007, 2:933-938. 10.1038/nprot.2007.106.
55. Plazas-Mayorca MD, Zee BM, Young NL, Fingerman IM, LeRoy G, Briggs SD, Garcia BA: One-pot shotgun quantitative mass spectrometry characterization of histones. J Proteome Res 2009, 8:5367-5374. 10.1021/pr900777e.
56. Byrum SD, Raman A, Taverna SD, Tackett AJ: ChAP-MS: a method for identification of proteins and histone posttranslational modifications at a single genomic locus. Cell Rep 2012, 2:198-205. 10.1016/j.celrep.2012.06.019.
57. Tackett AJ: The role of mass spectrometry in chromatin biology. J Proteomics Bioinform 2013, S2:1-2.
58. Déjardin J, Kingston RE: Purification of proteins associated with specific genomic loci. Cell 2009, 136:175-186. 10.1016/j.cell.2008.11.045.
59. Dammer EB, Fallini C, Gozal YM, Duong DM, Rossoll W, Xu P, Lah JJ, Levey AI, Peng J, Bassell GJ: Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS One 2012, 7:e38658. 10.1371/journal.pone.0038658.
60. Hathout Y: Approaches to the study of the cell secretome. Expert Rev Proteomics 2007, 4:239-248. 10.1586/14789450.4.2.239.
61. Kashyap MK, Harsha HC, Renuse S, Pawar H, Sahasrabuddhe NA, Kim MS, Marimuthu A, Keerthikumar S, Muthusamy B, Kandasamy K, Subbannayya Y, Prasad TS, Mahmood R, Chaerkady R, Meltzer SJ, Kumar RV, Rustgi AK, Pandey A: SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. Cancer Biol Ther 2010, 10:796-810. 10.4161/cbt.10.8.12914.
62. Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, Volbracht C, Schepers U, Imhof A, Hoffmeister A: Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 2012, 31:3157-3168. 10.1038/emboj.2012.173.
63. Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN: Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment. J Alzheimers Dis 2006, 10:391-397.
64. Butterfield DA, Sultana R: Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 2007, 12:61-72.
65. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin L-S, Li L: Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 2004, 279:13256-13264. 10.1074/jbc.M314124200.
66. Choi J, Rees HD, Weintraub ST, Levey AI, Chin L-S, Li L: Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 2005, 280:11648-11655. 10.1074/jbc.M414327200.
67. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin L-S, Li L: Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 2006, 281:10816-10824. 10.1074/jbc.M509079200.
68. Korolainen MA, Goldsteins G, Nyman TA, Alafuzoff I, Koistinaho J, Pirttilä T: Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol Aging 2006, 27:42-53. 10.1016/j.neurobiolaging.2004.11.010.
69. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA: Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 2008, 30:107-120. 10.1016/j.nbd.2007.12.007.
70. Reed TT, Pierce WM Jr, Turner DM, Markesbery WR, Allan Butterfield D: Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J Cell Mol Med 2009, 13:2019-2029. 10.1111/j.1582-4934.2008.00478.x.
71. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA: Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 2006, 27:1564-1576. 10.1016/j.neurobiolaging.2005.09.021.
72. Sultana R, Perluigi M, Newman SF, Pierce WM, Cini C, Coccia R, Butterfield DA: Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 2010, 12:327-336. 10.1089/ars.2009.2810.
73. Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I: Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology. Brain Pathol 2010, 20:222-233. 10.1111/j.1750-3639.2009.00266.x.
74. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA: Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003, 85:1394-1401. 10.1046/j.1471-4159.2003.01786.x.
75. Butterfield DA, Gu L, Domenico FD, Robinson RAS: Mass spectrometry and redox proteomics: applications in disease. Mass Spectrom Rev 2014, 33:277-301. 10.1002/mas.21374.
76. Ficarro SB, Parikh JR, Blank NC, Marto JA: Niobium (V) Oxide (Nb2O5): application to phosphoproteomics. Anal Chem 2008, 80:4606-4613. 10.1021/ac800564h.
77. Walsh Z, Paull B, Macka M: Inorganic monoliths in separation science: a review. Anal Chim Acta 2012, 750:28-47.
78. Xia Q, Cheng D, Duong DM, Gearing M, Lah JJ, Levey AI, Peng J: Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res 2008, 7:2845-2851. 10.1021/pr8000496.
79. Oppermann FS, Klammer M, Bobe C, Cox J, Schaab C, Tebbe A, Daub H: Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer. J Proteome Res 2013, 12:4089-4100. 10.1021/pr400417g.
80. Zhou H, Di Palma S, Preisinger C, Peng M, Polat AN, Heck AJR, Mohammed S: Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 2012, 12:260-271.
81. Monetti M, Nagaraj N, Sharma K, Mann M: Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat Methods 2011, 8:655-658. 10.1038/nmeth.1647.
82. Bak S, León IR, Jensen ON, Højlund K: Tissue specific phosphorylation of mitochondrial proteins isolated from rat liver, heart muscle, and skeletal muscle. J Proteome Res 2013, 12:4327-4339. 10.1021/pr400281r.
83. Trost M, Bridon G, Desjardins M, Thibault P: Subcellular phosphoproteomics. Mass Spectrom Rev 2010, 29:962-990. 10.1002/mas.20297.
84. Kunz RC, McAllister FE, Rush J, Gygi SP: A high-throughput, multiplexed kinase assay using a benchtop orbitrap mass spectrometer to investigate the effect of kinase inhibitors on kinase signaling pathways. Anal Chem 2012, 84:6233-6239. 10.1021/ac301116z.
85. Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Keri G, Mann M, Daub H: Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 2009, 8:1751-1764. 10.1074/mcp.M800588-MCP200.
86. Stokes MP, Farnsworth CL, Moritz A, Silva JC, Jia X, Lee KA, Guo A, Polakiewicz RD, Comb MJ: PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol Cell Proteomics 2012, 11:187-201. 10.1074/mcp.M111.015883.
87. Stokes MP, Silva JC, Jia X, Lee KA, Polakiewicz RD, Comb MJ: Quantitative profiling of DNA damage and apoptotic pathways in UV damaged cells using PTMScan direct. Int J Mol Sci 2012, 14:286-307. 10.3390/ijms14010286.
88. Hipkiss AR: Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 2006, 41:464-473. 10.1016/j.exger.2006.03.004.
89. Amani S, Naeem A: Understanding protein folding from globular to amyloid state: aggregation: darker side of protein. Process Biochem 2013, 48:1651-1664. 10.1016/j.procbio.2013.08.011.
90. Jellinger KA: Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 2010, 14:457-487.
91. Beyreuther K, Bush AI, Dyrks T, Hilbich C, Konig G, Monning U, Multhaup G, Prior R, Rumble B, Schubert W: Mechanisms of amyloid deposition in Alzheimer's disease. Ann N Y Acad Sci 1991, 640:129-139.
92. Gidalevitz T, Prahlad V, Morimoto RI: The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb Perspect Biol 2011,3(6):a009704.
93. Mattson MP, Chan SL, Duan W: Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 2002, 82:637-672.
94. Ramaswami M, Taylor JP, Parker R: Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 2013, 154:727-736. 10.1016/j.cell.2013.07.038.
95. Kato M, Han Tina W, Xie S, Shi K, Du X, Wu Leeju C, Mirzaei H, Goldsmith Elizabeth J, Longgood J, Pei J, Grishin Nick V, Frantz Douglas E, Schneider Jay W, Chen S, Li L, Sawaya Michael R, Eisenberg D, Tycko R, McKnight Steven L: Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 2012, 149:753-767. 10.1016/j.cell.2012.04.017.
96. Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL: Poly-dipeptides encoded by the C9ORF72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 2014, 345:1139-1145. 10.1126/science.1254917.
97. Walker LC, LeVine H: Corruption and spread of pathogenic proteins in neurodegenerative diseases. J Biol Chem 2012, 287:33109-33115. 10.1074/jbc.R112.399378.
98. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T: [alpha]-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002, 4:160-164.
99. Qing H, Wong W, McGeer EG, McGeer PL: Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun 2009, 387:149-152. 10.1016/j.bbrc.2009.06.142.
100. Bancher C, Grundke-Iqbal I, Iqbal K, Fried VA, Smith HT, Wisniewski HM: Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease. Brain Res 1991, 539:11-18. 10.1016/0006-8993(91)90681-K.
101. Hales CM, Dammer EB, Diner I, Yi H, Seyfried NT, Gearing M, Glass JD, Montine TJ, Levey AI, Lah JJ: Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease. Brain Pathol 2014, 24:344-351. 10.1111/bpa.12133.
102. Hales CM, Seyfried NT, Dammer EB, Duong D, Yi H, Gearing M, Troncoso JC, Mufson EJ, Thambisetty M, Levey AI: U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21. Mol Neurodegener 2014, 9:15. 10.1186/1750-1326-9-15.
103. Geschwind DH: Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 2003, 40:457-460. 10.1016/S0896-6273(03)00681-0.
104. Cook C, Carlomagno Y, Gendron TF, Dunmore J, Scheffel K, Stetler C, Davis M, Dickson D, Jarpe M, DeTure M, Petrucelli L: Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet 2013, 23:104-116.
105. Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, Lee VMY: The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2011, 2:252.
106. Min S-W, Cho S-H, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, Meyers D, Cole PA, Ott M, Gan L: Acetylation of Tau inhibits its degradation and contributes to Tauopathy. Neuron 2010, 67:953-966. 10.1016/j.neuron.2010.08.044.
107. Cohen TJ, Hwang AW, Unger T, Trojanowski JQ, Lee VMY: Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J 2012, 31:1241-1252. 10.1038/emboj.2011.471.
108. Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VM-Y: Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 Proteinopathies. J Biol Chem 2009, 284:8516-8524. 10.1074/jbc.M809462200.
109. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM-Y: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133. 10.1126/science.1134108.
110. Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC, Thambisetty M, Seyfried NT, Levey AI, Lah JJ: Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model. J Neurosci 2013, 33:19086-19098. 10.1523/JNEUROSCI.2508-13.2013.
111. Kummer MP, Heneka MT: Truncated and modified amyloid-beta species. Alzheimers Res Ther 2014, 6:28. 10.1186/alzrt258.
112. Kim HJ, Kim NC, Wang Y-D, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, Kanagaraj AP, Carter R, Boylan KB, Wojtas AM, Rademakers R, Pinkus JL, Greenberg SA, Trojanowski JQ, Traynor BJ, Smith BN, Topp S, Gkazi A-S, Miller J, Shaw CE, Kottlors M, Kirschner J, Pestronk A, Li YR, Ford AF, Gitler AD, et al.: Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013, 495:467-473. 10.1038/nature11922.
113. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin W-L, DeJesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW III, Rademakers R: Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013, 77:639. 10.1016/j.neuron.2013.02.004.
114. Komander D: Mechanism, Specificity and Structure of the Deubiquitinases. Heidelberg: Springer. 2010.
115. Wang X, Pattison JS, Su H: Posttranslational modification and quality control. Circ Res 2013, 112:367-381. 10.1161/CIRCRESAHA.112.268706.
116. Harper JW, Schulman BA: Structural complexity in ubiquitin recognition. Cell 2006, 124:1133-1136. 10.1016/j.cell.2006.03.009.
117. Fredrickson EK, Gardner RG: Selective destruction of abnormal proteins by ubiquitin-mediated protein quality control degradation. Semin Cell Dev Biol 2012, 23:530-537. 10.1016/j.semcdb.2011.12.006.
118. Willmund F, del Alamo M, Pechmann S, Chen T, Albanèse V, Dammer Eric B, Peng J, Frydman J: The cotranslational function of ribosome-associated Hsp70 in eukaryotic protein homeostasis. Cell 2013, 152:196-209. 10.1016/j.cell.2012.12.001.
119. Bengtson MH, Joazeiro CAP: Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature 2010, 467:470-473. 10.1038/nature09371.
120. Brandman O, Stewart-Ornstein J, Wong D, Larson A, Williams Christopher C, Li G-W, Zhou S, King D, Shen Peter S, Weibezahn J, Dunn Joshua G, Rouskin S, Inada T, Frost A, Weissman Jonathan S: A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 2012, 151:1042-1054. 10.1016/j.cell.2012.10.044.
121. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM: Recognition of the Polyubiquitin Proteolytic Signal. 2000.
122. Bedford L, Paine S, Rezvani N, Mee M, Lowe J, Mayer RJ: The UPS and autophagy in chronic neurodegenerative disease: six of one and half a dozen of the other-or not? Autophagy 2009, 5:224-227. 10.4161/auto.5.2.7389.
123. Jara JH, Frank DD, Ozdinler PH: Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1. Cell Biochem Biophys 2013, 67:45-53. 10.1007/s12013-013-9631-7.
124. McKinnon C, Tabrizi SJ: The ubiquitin-proteasome system in neurodegeneration. Antioxid Redox Signal 2014. E-pub ahead of print
125. Chen P-C, Bhattacharyya BJ, Hanna J, Minkel H, Wilson JA, Finley D, Miller RJ, Wilson SM: Ubiquitin homeostasis is critical for synaptic development and function. J Neurosci 2011, 31:17505-17513. 10.1523/JNEUROSCI.2922-11.2011.
126. Overk CR, Masliah E: Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol 2014, 88:508-516. 10.1016/j.bcp.2014.01.015.
127. Woltjer RL, Duerson K, Fullmer JM, Mookherjee P, Ryan AM, Montine TJ, Kaye JA, Quinn JF, Silbert L, Erten-Lyons D, Leverenz JB, Bird TD, Pow DV, Tanaka K, Watson GS, Cook DG: Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. J Neuropathol Exp Neurol 2010, 69:667-676. 10.1097/NEN.0b013e3181e24adb.
128. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA: Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002, 33:562-571. 10.1016/S0891-5849(02)00914-0.
129. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun J-A, Outzen H, Øvervatn A, Bjørkøy G, Johansen T: p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282:24131-24145. 10.1074/jbc.M702824200.
130. Kirkin V, Lamark T, Sou Y-S, Bjørkøy G, Nunn JL, Bruun J-A, Shvets E, McEwan DG, Clausen TH, Wild P: A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 2009, 33:505-516. 10.1016/j.molcel.2009.01.020.
131. Kirkin V, McEwan DG, Novak I, Dikic I: A role for ubiquitin in selective autophagy. Mol Cell 2009, 34:259-269. 10.1016/j.molcel.2009.04.026.
132. Tan JMM, Wong ESP, Kirkpatrick DS, Pletnikova O, Ko HS, Tay S-P, Ho MWL, Troncoso J, Gygi SP, Lee MK, Dawson VL, Dawson TM, Lim K-L: Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 2008, 17:431-439.
133. Funk KE, Mrak RE, Kuret J: Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol 2011, 37:295-306. 10.1111/j.1365-2990.2010.01135.x.
134. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H: p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002, 160:255-263. 10.1016/S0002-9440(10)64369-6.
135. Odagiri S, Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K: Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Acta Neuropathol 2012, 124:173-186. 10.1007/s00401-012-0975-7.
136. Kim PK, Hailey DW, Mullen RT, Lippincott-Schwartz J: Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc Natl Acad Sci 2008, 105:20567-20574. 10.1073/pnas.0810611105.
137. Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW: Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 2013, 496:372-376. 10.1038/nature12043.
138. Kim I, Rodriguez-Enriquez S, Lemasters JJ: Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007, 462:245-253. 10.1016/j.abb.2007.03.034.
139. Buchberger A, Bukau B, Sommer T: Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol Cell 2010, 40:238-252. 10.1016/j.molcel.2010.10.001.
140. Di Domenico F, Sultana R, Barone E, Perluigi M, Cini C, Mancuso C, Cai J, Pierce WM, Butterfield DA: Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects. J Proteome 2011, 74:1091-1103. 10.1016/j.jprot.2011.03.033.
141. Rexach JE, Clark PM, Mason DE, Neve RL, Peters EC, Hsieh-Wilson LC: Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation. Nat Chem Biol 2012, 8:253-261. 10.1038/nchembio.770.
142. Liao L, Pilotte J, Xu T, Wong CC, Edelman GM, Vanderklish P, Yates JR: BDNF induces widespread changes in synaptic protein content and up-regulates components of the translation machinery: an analysis using high-throughput proteomics. J Proteome Res 2007, 6:1059-1071. 10.1021/pr060358f.
143. Wang Z, Udeshi ND, O'Malley M, Shabanowitz J, Hunt DF, Hart GW: Enrichment and site mapping of O-Linked N-Acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry. Mol Cell Proteomics 2010, 9:153-160. 10.1074/mcp.M900268-MCP200.
144. Arnold CS, Johnson GVW, Cole RN, Dong DL-Y, Lee M, Hart GW: The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 1996, 271:28741-28744. 10.1074/jbc.271.46.28741.
145. Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ: Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 2012, 8:393-399. 10.1038/nchembio.797.
146. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O: Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 2011, 80:825-858. 10.1146/annurev-biochem-060608-102511.
147. Craig TJ, Henley JM: Protein SUMOylation in spine structure and function. Curr Opin Neurobiol 2012, 22:480-487. 10.1016/j.conb.2011.10.017.
148. Sunyer B, Diao W, Lubec G: The role of post-translational modifications for learning and memory formation. Electrophoresis 2008, 29:2593-2602. 10.1002/elps.200700791.
149. Janke C, Kneussel M: Tubulin post-translational modifications: encoding functions on the neuronal microtubule cytoskeleton. Trends Neurosci 2010, 33:362-372. 10.1016/j.tins.2010.05.001.
150. Song Y, Kirkpatrick Laura L, Schilling Alexander B, Helseth Donald L, Chabot N, Keillor Jeffrey W, Johnson Gail VW, Brady Scott T: Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron 2013, 78:109-123. 10.1016/j.neuron.2013.01.036.
151. Ngounou Wetie AG, Sokolowska I, Woods AG, Wormwood KL, Dao S, Patel S, Clarkson BD, Darie CC: Automated mass spectrometry-based functional assay for the routine analysis of the secretome. J Lab Autom 2013, 18:19-29. 10.1177/2211068212454738.
152. Nijholt DA, De Kimpe L, Elfrink HL, Hoozemans JJ, Scheper W: Removing protein aggregates: the role of proteolysis in neurodegeneration. Curr Med Chem 2011, 18:2459-2476. 10.2174/092986711795843236.
153. Herskowitz JH, Gozal YM, Duong DM, Dammer EB, Gearing M, Ye K, Lah JJ, Peng J, Levey AI, Seyfried NT: Asparaginyl endopeptidase cleaves TDP-43 in brain. Proteomics 2012, 12:2455-2463. 10.1002/pmic.201200006.
154. Fonović M, Bogyo M: Activity-based probes as a tool for functional proteomic analysis of proteases. Expert Rev Proteomics 2008, 5:721-730. 10.1586/14789450.5.5.721.
155. Fan F, Nie S, Dammer EB, Duong DM, Pan D, Ping L, Zhai L, Wu J, Hong X, Qin L: Protein profiling of active cysteine cathepsins in living cells using an activity-based probe containing a cell-penetrating peptide. J Proteome Res 2012, 11:5763-5772.
156. Böttcher T, Pitscheider M, Sieber SA: Natural products and their biological targets: proteomic and metabolomic labeling strategies. Angew Chem Int Ed 2010, 49:2680-2698. 10.1002/anie.200905352.
157. Tweedie-Cullen RY, Brunner AM, Grossmann J, Mohanna S, Sichau D, Nanni P, Panse C, Mansuy IM: Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One 2012, 7:e36980. 10.1371/journal.pone.0036980.